Why do phase III trials of promising heart failure drugs often fail? The contribution of regression to the truth

Henry Krum, Andrew M Tonkin

Research output: Contribution to journal › Article › Research › peer-review

25 Citations (Scopus)

Access to Document

@article{b6db1bc99ef44dd9ac5aebc305298e2f,

title = "Why do phase III trials of promising heart failure drugs often fail? The contribution of regression to the truth",

author = "Henry Krum and Tonkin, {Andrew M}",

year = "2003",

doi = "10.1054/S1071-9164(03)00018-6",

language = "English",

volume = "9",

pages = "364 -- 367",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Why do phase III trials of promising heart failure drugs often fail? The contribution of regression to the truth

AU - Krum, Henry

AU - Tonkin, Andrew M

PY - 2003

Y1 - 2003

U2 - 10.1054/S1071-9164(03)00018-6

DO - 10.1054/S1071-9164(03)00018-6

M3 - Article

SN - 1071-9164

VL - 9

SP - 364

EP - 367

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 5

ER -